Edgewise Therapeutics, Inc. (EWTX)
26.60
-1.57
(-5.57%)
USD |
NASDAQ |
Jan 15, 16:00
26.55
-0.05
(-0.19%)
After-Hours: 20:00
Edgewise Therapeutics SG&A Expense (TTM): 36.80M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Dynavax Technologies Corp. | 179.71M |
| Omeros Corp. | 44.20M |
| Gilead Sciences, Inc. | 5.886B |
| Agios Pharmaceuticals, Inc. | 180.37M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |